Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Carnosine for Oxaliplatin-induced Peripheral Neuropathy
NCT02808624Phase 2Completed
- Sponsor
- Cairo University
- Start
- Jun 2015
- Primary completion
- Nov 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of carnosine in peripheral neuropathy, sponsored by Cairo University. Primary endpoints: Common Terminology Criteria for Adverse Events at 3 months and Oxidative stress markers at 3 months. Started Jun 2015; status: completed.
02
Drugs
carnosine
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT02808624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02808624.